Effects of Dopaminergic Agonists and Antagonists on the Muscarinic and Dopaminergic Receptors from Rat Neostriatum

Alburges, 1993, Effects on monoamine levels in rat CNS after chronic administration of cocaine, Invest. Clin., 34, 181 Ajima, 1990, Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions, Brain Res., 518, 193, 10.1016/0006-8993(90)90972-E Bertorelli, 1990, D1 and D2 Dopaminergic regulation of acetylcholine release from striata of freely moving rats, J. Neurochem., 54, 2145, 10.1111/j.1471-4159.1990.tb04922.x Creese, 1980, Chronic neuroleptic treatment and dopamine receptor regulation, Adv. Biochem. Psychopharmacol., 24, 89 Damsma, 1990, Dopaminergic regulation of striatal cholinergic interneurons, Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 523, 10.1007/BF00169040 Damsma, 1990, Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat, Eur. J. Pharmacol., 186, 335, 10.1016/0014-2999(90)90456-G De Boer, 1990, Dopaminergic—cholinergic interactions in the striatum, Naunym-Schmiedeberg's Arch. Pharmacol., 342, 528, 10.1007/BF00169041 Dombrowski, 1983, Muscarinic receptor binding and oxidative activities in the adult rat superior cervical ganglion, J. Neurosci., 3, 1963, 10.1523/JNEUROSCI.03-10-01963.1983 Friedman, 1990, Decreased striatal release of acetylcholine following withdrawal from long-term treatment with haloperidol, Neuropharmacol., 29, 537, 10.1016/0028-3908(90)90065-Y Joyce, 1991, Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine, Exp. Neurol., 113, 261, 10.1016/0014-4886(91)90016-6 Kessler, 1991, High affinity dopamine D2 receptors, Life Sci., 49, 617, 10.1016/0024-3205(91)90261-9 Kubota, 1987, Neostriatal cholinergic neurons receive direct synaptic inputs from dopaminergic axons, Brain Res., 413, 179, 10.1016/0006-8993(87)90167-3 Lacey, 1989, Towards understand dopamine, Seminar Neurosci., 1, 137 Lehmann, 1983, The striatal cholinergic interneuron, Neurosci., 10, 1105, 10.1016/0306-4522(83)90102-1 Le Moine, 1991, Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor Gene, Proc. Natl. Acad. Sci. USA, 88, 4205, 10.1073/pnas.88.10.4205 Le Moine, 1990, D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum, Neuroxi. Lett., 117, 248, 10.1016/0304-3940(90)90671-U Levin, 1990, Cholinergic-dopaminergic interactions in cognitive performance, Beh. Neural Biol., 54, 271, 10.1016/0163-1047(90)90639-N Lowry, 1951, Protein measurement with the folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Meltzer, 1989, Classification of typical and atypical antipsychotic drugs no the basis of dopamine D1- and D-2 and serotonin pK1 values, J. Pharmacol. Exp. Ther., 251, 238 Missale, 1989, Repeated reserpine administration up-regulates the transduction mechanism of D1 receptors without changing the density of 3H-SCH 23390 binding, Brain Res., 483, 117, 10.1016/0006-8993(89)90041-3 Porceddu, 1986, 3H-SCH 23390 binding sites in the rat substancia nigra, Life Sci., 39, 321, 10.1016/0024-3205(86)90650-8 Scatton, 1982, Further evidence for the involvement of D2 but not D1 receptors in dopaminergic control of striatal cholinergic transmission, Life Sci., 31, 2883, 10.1016/0024-3205(82)90679-8 Scatton, 1982, Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat, J. Pharmacol. Exp. Ther., 220, 197 Seeman, 1987, Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's Disease, Neuropsychopharmacol., 1, 5, 10.1016/0893-133X(87)90004-2 Seiler, 1984, Mol. Pharmacol., 26, 452 Sethy, 1985, Effect of dopaminergic drugs on striatal acethylcholine concentration, J. Pharm. Pharmacol., 37, 73, 10.1111/j.2042-7158.1985.tb04939.x Sigala, 1991, Low doses of L-sulpiride down-regulate striatal and cortical dopamine receptors and B-adrenoceptors, Eur. J. Pharmacol., 199, 247, 10.1016/0014-2999(91)90465-3 Smith, 1976, Behavioral evidence for supersensivity after administration of haloperidol, clozapine and thioridazine, Life Sci., 19, 725, 10.1016/0024-3205(76)90170-3 Sokoloff, 1990, Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics, Nature, 347, 146, 10.1038/347146a0 Sousa, 1995, Effect of pimozide on the increase of muscarinic receptors caused by mazindol and apomorphine in the rat cerebral motor cortex, Braz. J. Med. Biol. Res., 28, 113 Spano, 1978, Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system, Adv. Biochem. Psychopharmacol., 19, 155 Spano, 1983, Stimulation of D2 dopamine receptors by dopaminergic ergot alkaloids, 165 Stoof, 1992, In vitro and in vivo acetylcholine release from rat striatum as a function paradigm of signal transduction via a D2 dopamine receptor, Neurochem. Int., 20, 201S, 10.1016/0197-0186(92)90239-N Stoof, 1982, Independent in vitro regulation by the D2 dopamine receptor of dopamine stimulated cyclic AMP efflux and K+ stimulated release of acetylcholine from rat striatum, Brain Res., 250, 263, 10.1016/0006-8993(82)90420-6 Van Tol, 1991, Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine, Nature, 350, 610, 10.1038/350610a0 Viana, 1992, Effect of mazindol administration on (3H)-N-methylscopolamimne binding to rat cerebral cortex, Life Sci., 50, 549, 10.1016/0024-3205(92)90366-W Wang, 1993, Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists, Neuropharmacology, 32, 85, 10.1016/0028-3908(93)90133-N Weiner, 1991, D1 and D2 dopamine receptor mRNA in rat brain, Proc. Natl. Acad. Sci. USA, 88, 1859, 10.1073/pnas.88.5.1859